Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients. - Wikidata - wikimedia - TriplyDB

Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients.

Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients.

http://www.wikidata.org/entity/Q54546383

about

Increased Dicarbonyl Stress as a Novel Mechanism of Multi-Organ Failure in Critical Illness "Immunonutrition" Has Failed to Improve Peritonitis-Induced Septic Shock in Rodents.Nutrition before and during Surgery and the Inflammatory Response of the Heart: A Randomized Controlled Trial Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies Arginine appearance and nitric oxide synthesis in critically ill infants can be increased with a protein-energy-enriched enteral formula Argininemia and plasma arginine bioavailability - predictive factors of mortality in the severe trauma patients?Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis.Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management Nutrition optimization prior to surgery.Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model.Pros and cons of feeding the septic intensive care unit patient.Associations of Plasma Nitrite, L-Arginine and Asymmetric Dimethylarginine with Morbidity and Mortality in Patients with Necrotizing Soft Tissue Infections.Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.When Is It Appropriate to Use Arginine in Critical Illness?Parenteral or Enteral Arginine Supplementation Safety and Efficacy.Markers of nitric oxide are associated with sepsis severity: an observational study The Arginine/ADMA Ratio Is Related to the Prevention of Atherosclerotic Plaques in Hypercholesterolemic Rabbits When Giving a Combined Therapy with Atorvastatine and Arginine.Determination of homoarginine, arginine, NMMA, ADMA, and SDMA in biological samples by HPLC-ESI-mass spectrometry.Chronic Critical Illness: Application of What We Know.

P2860

Q30236047-041B5E2D-8591-4408-B73F-14A27CC752CD Q35903913-8E9DD6D4-D89C-4553-A9A1-543B181BFF30 Q35941757-A8342EA6-B1CE-4E33-A1F5-B0A7093EFD49 Q36182184-2C8A73AC-62C7-4401-B281-A4213410E594 Q37187246-EABA1DB8-AF88-44F1-9757-6296A4FE55D5 Q37220937-B8D53938-29AB-42AC-B838-D02F3A41A3AC Q37602513-C9EC6B0D-297D-4910-9D75-A29CF546495C Q37704715-72C804C4-C72B-4C24-A42C-ECF8B22DB6C6 Q38138969-3261BA8B-37C7-40D9-A412-11F3A6046444 Q38172080-1FD599C4-340E-4017-9935-D5DFD09F602C Q38194032-BB611E61-8857-4F99-99B6-62BD6F97A9C2 Q38412077-55857F83-2E5A-44A4-BC34-4DEA903AF67D Q38597876-87B94ACB-0146-4199-A5AC-766CF832B2D8 Q38635782-E661359D-683A-43D9-9569-D70239717BF3 Q38851122-C40EDBFB-77AE-4E7A-8020-C644AA2EA81E Q39033973-2D131705-5BEA-475D-98EA-A44E0A25C4AA Q41033479-A2A86F50-1D00-4B6B-A07A-BB0E177DA70C Q41456914-3CC16CE1-9333-4BD7-A24F-3EBF2DBEBDBD Q42916663-493C71B1-F06C-4BC6-883B-8909CB271A41 Q50091197-4AFA63D6-D097-47F8-89C5-0F4C90EF9E76

P2860

Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients.

http://www.wikidata.org/entity/Q54546383

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Imbalance of arginine and asym ...... d mortality in shock patients.

@en

Imbalance of arginine and asym ...... d mortality in shock patients.

@nl

type

label

Imbalance of arginine and asym ...... d mortality in shock patients.

@en

Imbalance of arginine and asym ...... d mortality in shock patients.

@nl

prefLabel

Imbalance of arginine and asym ...... d mortality in shock patients.

@en

Imbalance of arginine and asym ...... d mortality in shock patients.

@nl

P1433

Q54546383-2FE31596-8923-492A-951E-2296039777E8

P1476

Q54546383-81437F79-48AE-418C-B661-2F28F5F1A776

P2093

Q54546383-122F4E69-FC72-4F75-96EF-A194112F87E8

Q54546383-192A94C3-CD47-48F2-A2F6-D39955EA791A

Q54546383-809F5BC8-632A-4990-856D-C264803A7E36

Q54546383-81C690F2-96B4-4B02-8A6B-886A3A33041C

Q54546383-856801AF-673A-4079-8FCA-A8CE1088369E

Q54546383-BE42466E-1EDF-4A93-92D5-C678A7C40338

Q54546383-D67E3B7E-C340-49C0-A703-9EC7E5829542

Q54546383-D7E62158-AA15-4CC6-8417-A3011C90A3BF

Q54546383-EF6F9AF7-2FB2-4CB9-8E27-07F70EE4F30A

Q54546383-FA8D538C-B192-4AB4-ACC3-2444E085EB6A

P2860

Q54546383-01BFF394-E174-4286-B45D-80D934686B0C

Q54546383-0C93EC33-9660-4BAE-B05B-AC4FB7989538

Q54546383-0CEA69C3-62AB-47DB-BB11-EE9AE0B19552

Q54546383-12B4AC4A-115C-466B-8CFC-630DFD00CDBD

Q54546383-2BD05328-193B-4403-AC5F-21E244EFEA8E

Q54546383-2F280494-6AE4-4EBF-A3EE-EE31DFDE63CD

Q54546383-31CD03AE-0A92-48B2-9FDA-22AA176518CF

Q54546383-36111BFE-7A60-4441-80E9-F506924BE3FF

Q54546383-39BFA776-BF7E-477D-BF64-3CCFEA75E099

Q54546383-44C95E6A-98E8-4EBF-A1E3-6F63F93B6591

P304

Q54546383-EA3D7444-A8C5-457E-9224-D77E90CD9630

P31

Q54546383-493B1F62-27D1-40DA-9A58-A0D7E7A81F86

P356

Q54546383-E2D7A032-181B-435A-BE17-B625722C82A4

P433

Q54546383-4B6198F7-7040-4F23-A65E-D2E1B5C0A18B

P478

Q54546383-C4F72A37-702A-44D4-9C0A-7110A428D6BC

P577

Q54546383-669A708B-691F-4036-8858-7F12A3AAA247

P698

Q54546383-A49C9D8E-EE11-4720-B82F-2C2A20146618

P356

S0007114511004648

P1433

British Journal of Nutrition

P1476

Imbalance of arginine and asym ...... d mortality in shock patients.

@en

P2093

Alexander P J Houdijk

http://www.w3.org/2001/XMLSchema#string

Bas A J M de Mol

http://www.w3.org/2001/XMLSchema#string

Heleen M Oudemans-van Straaten

http://www.w3.org/2001/XMLSchema#string

Marlieke Visser

http://www.w3.org/2001/XMLSchema#string

Mechteld A R Vermeulen

http://www.w3.org/2001/XMLSchema#string

Milan C Richir

http://www.w3.org/2001/XMLSchema#string

Paul A M van Leeuwen

http://www.w3.org/2001/XMLSchema#string

Piet J Kostense

http://www.w3.org/2001/XMLSchema#string

Tom Teerlink

http://www.w3.org/2001/XMLSchema#string

Willem Wisselink

http://www.w3.org/2001/XMLSchema#string

P2860

APACHE II: a severity of disease classification system

Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis.

Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials.

Immune-modulatory actions of arginine in the critically ill.

Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance.

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.

The ratio of arginine to dimethylarginines is reduced and predicts outcomes in patients with severe sepsis.

HPLC analysis of ADMA and other methylated L-arginine analogs in biological fluids.

Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury.

The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.

P304

1458-1465

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0007114511004648

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22129964

http://www.w3.org/2001/XMLSchema#string